These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers. Glassman SD, Dimar JR, Burkus K, Hardacker JW, Pryor PW, Boden SD, Carreon LY. Spine (Phila Pa 1976); 2007 Jul 01; 32(15):1693-8. PubMed ID: 17621221 [Abstract] [Full Text] [Related]
4. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Crawford CH, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD. Spine (Phila Pa 1976); 2009 Jun 01; 34(13):1390-4. PubMed ID: 19440166 [Abstract] [Full Text] [Related]
5. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft. Maeda T, Buchowski JM, Kim YJ, Mishiro T, Bridwell KH. Spine (Phila Pa 1976); 2009 Sep 15; 34(20):2205-12. PubMed ID: 19752707 [Abstract] [Full Text] [Related]
7. Posterolateral lumbar spine fusion with INFUSE bone graft. Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. Spine J; 2007 Sep 15; 7(1):44-9. PubMed ID: 17197332 [Abstract] [Full Text] [Related]
8. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Buttermann GR. Spine J; 2008 Sep 15; 8(3):426-35. PubMed ID: 17977799 [Abstract] [Full Text] [Related]
9. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Haid RW, Branch CL, Alexander JT, Burkus JK. Spine J; 2004 Sep 15; 4(5):527-38; discussion 538-9. PubMed ID: 15363423 [Abstract] [Full Text] [Related]
14. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions. Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D. Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173 [Abstract] [Full Text] [Related]
15. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, Djurasovic M, Dimar JR. Spine J; 2008 Jan 15; 8(3):443-8. PubMed ID: 17526436 [Abstract] [Full Text] [Related]
16. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications. Malham GM, Parker RM, Ellis NJ, Blecher CM, Chow FY, Claydon MH. J Neurosurg Spine; 2014 Dec 15; 21(6):851-60. PubMed ID: 25279655 [Abstract] [Full Text] [Related]
19. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin. Singh K, Smucker JD, Ugbo JL, Tortolani PJ, Tsai L, Fei Q, Kuh S, Rumi M, Heller JG, Boden SD, Yoon ST. Spine J; 2007 Dec 15; 7(3):326-31. PubMed ID: 17482116 [Abstract] [Full Text] [Related]
20. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Akamaru T, Suh D, Boden SD, Kim HS, Minamide A, Louis-Ugbo J. Spine (Phila Pa 1976); 2003 Mar 01; 28(5):429-34. PubMed ID: 12616152 [Abstract] [Full Text] [Related] Page: [Next] [New Search]